Allo-reactive T cells for the treatment of hematological malignancies-Reference-Cited by-同舟云学术

Allo-reactive T cells for the treatment of hematological malignancies

Published:2015-10-24 Issue:10 Volume:9 Page:1894-1903
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Falkenburg J.H.F.,Jedema I.

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Reference85 articles.

1. Targeting B cell leukemia with highly specific allogeneic T cells with a public recognition motif;Abrahamsen;Leukemia,2010

2. Identification of a polymorphic gene, BCL2A1, encoding two novel hematopoietic lineage-specific minor histocompatibility antigens;Akatsuka;J. Exp. Med,2003

3. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity;Alexander-Miller;J. Immunol,1993

4. Allo-HLA reactivity of virus-specific memory T-cells is common;Amir;Blood,2010

5. Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific;Amir;Blood,2011

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation;Frontiers in Immunology;2024-03-13

2. T cell receptor-engineered T cells derived from target human leukocyte antigen-DPB1-specific T cell can be a potential tool for therapy against leukemia relapse following allogeneic hematopoietic cell transplantation;NAGOYA J MED SCI;2023

3. Association between CD34+ and CD3+ T-cells in allogeneic grafts and acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation: A single-center study;Transplant Immunology;2023-04

4. Feasibility, safety, and efficacy of early prophylactic donor lymphocyte infusion after T cell-depleted allogeneic stem cell transplantation in acute leukemia patients;Annals of Hematology;2023-03-07

5. Promiscuity of Peptides Presented in HLA-DP Molecules from Different Immunogenicity Groups Is Associated With T-Cell Cross-Reactivity;Frontiers in Immunology;2022-02-16